90 related articles for article (PubMed ID: 1383889)
1. Autoradiographic localization of [125I]charybdotoxin binding sites in rat brain.
Gehlert DR; Gackenheimer SL; Robertson DW
Neurosci Lett; 1992 Jun; 140(1):25-9. PubMed ID: 1383889
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the distribution of binding sites for the potassium channel ligands [125I]apamin, [125I]charybdotoxin and [125I]iodoglyburide in the rat brain.
Gehlert DR; Gackenheimer SL
Neuroscience; 1993 Jan; 52(1):191-205. PubMed ID: 7679479
[TBL] [Abstract][Full Text] [Related]
3. Characterization of high affinity binding sites for charybdotoxin in synaptic plasma membranes from rat brain. Evidence for a direct association with an inactivating, voltage-dependent, potassium channel.
Vázquez J; Feigenbaum P; King VF; Kaczorowski GJ; Garcia ML
J Biol Chem; 1990 Sep; 265(26):15564-71. PubMed ID: 1697593
[TBL] [Abstract][Full Text] [Related]
4. Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels.
Giangiacomo KM; Sugg EE; Garcia-Calvo M; Leonard RJ; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 1993 Mar; 32(9):2363-70. PubMed ID: 7680230
[TBL] [Abstract][Full Text] [Related]
5. Interactions between dendrotoxin, a blocker of voltage-dependent potassium channels, and charybdotoxin, a blocker of calcium-activated potassium channels, at binding sites on neuronal membranes.
Harvey AL; Marshall DL; De-Allie FA; Strong PN
Biochem Biophys Res Commun; 1989 Aug; 163(1):394-7. PubMed ID: 2476127
[TBL] [Abstract][Full Text] [Related]
6. Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
Gehlert DR; Gackenheimer SL; Mais DE; Robertson DW
J Pharmacol Exp Ther; 1991 May; 257(2):901-7. PubMed ID: 1903447
[TBL] [Abstract][Full Text] [Related]
7. Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. Evidence for a direct association with the high conductance calcium-activated potassium channel.
Vázquez J; Feigenbaum P; Katz G; King VF; Reuben JP; Roy-Contancin L; Slaughter RS; Kaczorowski GJ; Garcia ML
J Biol Chem; 1989 Dec; 264(35):20902-9. PubMed ID: 2480347
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-controlled binding of a peptide neurotoxin to its K+ channel receptor.
Miller C
Biochemistry; 1990 Jun; 29(22):5320-5. PubMed ID: 1696498
[TBL] [Abstract][Full Text] [Related]
9. Charybdotoxin is a new member of the K+ channel toxin family that includes dendrotoxin I and mast cell degranulating peptide.
Schweitz H; Bidard JN; Maes P; Lazdunski M
Biochemistry; 1989 Dec; 28(25):9708-14. PubMed ID: 2482078
[TBL] [Abstract][Full Text] [Related]
10. [125I]margatoxin, an extraordinarily high affinity ligand for voltage-gated potassium channels in mammalian brain.
Knaus HG; Koch RO; Eberhart A; Kaczorowski GJ; Garcia ML; Slaughter RS
Biochemistry; 1995 Oct; 34(41):13627-34. PubMed ID: 7577952
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in a Shaker K+ channel changes its charybdotoxin binding site from low to high affinity.
Goldstein SA; Miller C
Biophys J; 1992 Apr; 62(1):5-7. PubMed ID: 1376173
[No Abstract] [Full Text] [Related]
12. Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel.
Deutsch C; Price M; Lee S; King VF; Garcia ML
J Biol Chem; 1991 Feb; 266(6):3668-74. PubMed ID: 1704892
[TBL] [Abstract][Full Text] [Related]
13. Noxiustoxin and leiurutoxin III, two homologous peptide toxins with binding properties to synaptosomal membrane K+ channels.
Valdivia HH; Martin BM; Escobar L; Possani LD
Biochem Int; 1992 Sep; 27(6):953-62. PubMed ID: 1280139
[TBL] [Abstract][Full Text] [Related]
14. Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor.
MacKinnon R; Miller C
Science; 1989 Sep; 245(4924):1382-5. PubMed ID: 2476850
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of potassium ion channels on human T lymphocytes.
Michne WF; Guiles JW; Treasurywala AM; Castonguay LA; Weigelt CA; Oconnor B; Volberg WA; Grant AM; Chadwick CC; Krafte DS
J Med Chem; 1995 May; 38(11):1877-83. PubMed ID: 7540207
[TBL] [Abstract][Full Text] [Related]
16. Charybdotoxin blocks both Ca-activated K channels and Ca-independent voltage-gated K channels in rat brain synaptosomes.
Schneider MJ; Rogowski RS; Krueger BK; Blaustein MP
FEBS Lett; 1989 Jul; 250(2):433-6. PubMed ID: 2473920
[TBL] [Abstract][Full Text] [Related]
17. Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin.
Stampe P; Kolmakova-Partensky L; Miller C
Biochemistry; 1994 Jan; 33(2):443-50. PubMed ID: 7506933
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of sapecin and sapecin B.
Kim JI; Iwai H; Kurata S; Takahashi M; Masuda K; Shimada I; Natori S; Arata Y; Sato K
FEBS Lett; 1994 Apr; 342(2):189-92. PubMed ID: 7511542
[TBL] [Abstract][Full Text] [Related]
19. WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Hill RJ; Grant AM; Volberg W; Rapp L; Faltynek C; Miller D; Pagani K; Baizman E; Wang S; Guiles JW
Mol Pharmacol; 1995 Jul; 48(1):98-104. PubMed ID: 7542739
[TBL] [Abstract][Full Text] [Related]
20. Margatoxin increases dopamine release in rat striatum via voltage-gated K+ channels.
Saria A; Seidl CV; Fischer HS; Koch RO; Telser S; Wanner SG; Humpel C; Garcia ML; Knaus HG
Eur J Pharmacol; 1998 Feb; 343(2-3):193-200. PubMed ID: 9570467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
